The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia – Response to Rashidi et al.

Andrew Kenneth McGregorDepartment of Hematology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Correspondence[email protected]

Deborah MoultonDepartment of Hematology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;

Nick BownNorthern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;

Gavin CuthbertNorthern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;

David BournNorthern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;

Susanna MathewDepartment of Hematology, City Hospitals Sunderland NHS Foundation Trust, Sunderland, UK;

Raymond DangDepartment of Hematology, South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK;

Phillip MounterDepartment of Hematology, North Tees and Hartlepool Hospitals NHS Foundation Trust, Stockton-on-Tees, UK

Gail JonesDepartment of Hematology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;

Your download is now in progress and you may close this window